EMA Withdrawn: Prepandrix (A/Indonesia/05/2005 (H5N1) like strain used (PR8-IBCDC-RG2)) — GlaxoSmithKline Biologicals S.A.

View source ↗

Summary

The EMA indicates withdrawal of Prepandrix, an influenza vaccine, from the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disease Outbreaks

Drugs mentioned

• Prepandrix

Snippet

Status: Withdrawn. Therapeutic area: Influenza, Human;Immunization;Disease Outbreaks. MAH: GlaxoSmithKline Biologicals S.A.. Decision date: 20/09/2018. Accelerated assessment